Issue 37 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

"These are Life-Saving Drugs. I'm Not Going To Stop Treating Patients, Right?"

Fake Avastin, Paid for by Medicare, Administered to U.S. Patients

Gonzalez-Angulo To Serve 10 Years In Poisoning Case

FDA Publishes Two Guidances for Lab-Developed Tests

Groups Push For CMS Coverage For LDCT Lung Screening

In Brief

Platanias Appointed Director Of Lurie Cancer Center

Karmanos Cancer Institute and Wayne State sign new affiliation agreement

Robert Miller named medical director of ASCO Institute of Quality

MD Anderson Cancer Center receives $10 million from ExxonMobil

Jan Egberts appointed CEO of Agendia Inc.

Memorial Sloan Kettering to open largest suburban location

CancerCare receives $1.5 million from Susan G. Komen

Funding Opportunities

NYC-Based Research Alliance Offering $200,000 per Year for Young Investigators

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login